共 50 条
- [21] Influence of HLA-DQA1*05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (08): : 869 - 871
- [23] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
- [24] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
- [26] Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1146 - 1151
- [27] Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis PHARMACOGENOMICS JOURNAL, 2017, 17 (05): : 403 - 411
- [28] Safety of anti-TNF treatment in older IBD patients: a systematic review and meta-analysis JOURNAL OF CROHNS & COLITIS, 2017, 11 : S248 - S248
- [29] Anti-TNF Alpha and Risk of Lymphoma in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis MEDICINA-LITHUANIA, 2024, 60 (07):
- [30] Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis The Pharmacogenomics Journal, 2017, 17 : 403 - 411